Innate Pharma SA (Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, announces that it will participate in the following investor conferences in the coming weeks:
- Paris Midcap Event, Palais Brongniard, Paris, on September 22 & 23, 2011;
- BIO Investor Forum, Palace Hotel, San Francisco, on October 25 & 26, 2011. During this event, Hervé Brailly, CEO of Innate Pharma, will participate in a panel on Cancer Immunotherapy (Immunotherapy: Heal Thyself, Tuesday, October 25th, 10:30am-11:25am, Twin Peaks N/S).
| PR in English | 33.59 KB |
| CP en français | 33.33 KB |